24 October 2020>: Clinical Research
Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant : A Retrospective Study
Gefei He 1DEGF* , Juanjuan Huang 1DEF* , Shiqiong Huang 1B , Ji Sun 1C , Yulv Zhou 2B , Hong Tan 3B , Hui Shen 4C , Zhuan Li 1AG* , Jiyang Liu 1AG*DOI: 10.12659/MSM.925693
Med Sci Monit 2020; 26:e925693
Table 2 Drug sensitivity of CRKP strains.
Antimicrobial agent | Number of resistant strains | Drug resistance rate (%) |
---|---|---|
Ampicillin | 97 | 100.00 |
Ampicillin/sulbactam | 97 | 100.00 |
Piperacillin/sulbactam | 97 | 100.00 |
Cefazolin | 97 | 100.00 |
Ceftazidime pentahydrate | 97 | 100.00 |
Ceftriaxone sodium | 97 | 100.00 |
Cefepime | 97 | 100.00 |
Cefotetan | 97 | 100.00 |
Aztreonam | 97 | 100.00 |
Imipenem | 97 | 100.00 |
Ertapenem | 97 | 100.00 |
Amikacin | 47 | 48.45 |
Gentamicin | 58 | 59.79 |
Tobramycin | 62 | 63.92 |
Levofloxacin tablets | 92 | 94.85 |
Ciprofloxacin | 92 | 94.85 |
Furadantin | 97 | 100.00 |
Compound sulfamethoxazole | 21 | 21.65 |